605 results on '"Azim, Hatem A."'
Search Results
2. Role of GnRH Agonists for Fertility Preservation in Breast Cancer
3. Safety and Challenges of Pregnancy in Women with a History of Endocrine-Sensitive Breast Cancer
4. Epidemiology and General Considerations of Pregnancy Following Cancer Diagnosis
5. Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial
6. Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review
7. Taxanes for the treatment of breast cancer during pregnancy: an international cohort study
8. Breast Cancer in Special Groups: Breast Cancer in Pregnancy
9. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
10. Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer
11. The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients
12. Breast Cancer in Pregnancy and Fertility Preservation
13. The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
14. List of contributors
15. Molecular biology of breast cancer
16. Fertility Issues in Patients with Breast Cancer or Survivors
17. Safety and Challenges of Pregnancy in Women with a History of Endocrine-Sensitive Breast Cancer
18. Role of GnRH Agonists for Fertility Preservation in Breast Cancer
19. Epidemiology and General Considerations of Pregnancy Following Cancer Diagnosis
20. Managing Breast Cancer in Young Women
21. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
22. Supplementary Figure 4 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
23. Supplementary Figure 3 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
24. Table S 1-6 and Figures S1-3 from Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221
25. Supplementary Figure 6 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
26. Supplementary Figure 8 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
27. Supplementary Figure 1 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
28. Supplementary Figure 7 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
29. Supplementary Figure 2 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
30. Supplementary Figure Legends 1-8 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
31. Supplementary Figure 5 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
32. Abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13)
33. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
34. Safety of pregnancy after early breast cancer in young women with hormone receptor-positive disease :a systematic review and meta-analysis
35. Molecular Biology of Breast Cancer
36. List of Contributors
37. The Landscape of BRCAMutations among Egyptian Women with Breast Cancer
38. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?
39. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
40. First international consensus guidelines for breast cancer in young women (BCY1)
41. Breast Cancer in Special Groups: Breast Cancer in Pregnancy
42. Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial
43. Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
44. Immediate breast reconstruction with expander in pregnant breast cancer patients
45. RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial
46. Prevention and management of major side effects of targeted agents in breast cancer
47. Cancer of the breast
48. Abstract P3-23-03: Use of taxane-containing regimens during pregnancy for the treatment of breast cancer: A systematic review
49. Abstract PD5-06: Safety of assisted reproductive technologies (ART) following treatment completion in young women with germline BRCA pathogenic variants having a pregnancy after breast cancer
50. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.